Theranovis Dental Gel in Patients With Gingivitis
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMedical University of Graz
About this trial
The aim of this randomized, blinded, controlled study is to compare the theranovis dental gel with a placebo product in order to determine whether an improvement in oral health can be achieved in patients with gingivitis.
Eligibility criteria
Qualifiers
Male and female participants aged over 18 years
At least 12 teeth per jaw (natural teeth, including restorations such as crowns and implants)
Smokers (less than 10 cigarettes per day)
Gingivitis with intact periodontium (probing depth ≤ 3.0 mm, bleeding on probing > 10%)
Disqualifiers
Male and female participants under 18 years of age
Fewer than 12 teeth per jaw
Individuals not capable of giving informed consent
Individuals with hypersensitivity or allergies to any of the study product ingredients
Trial design
Treatments tested in this trial
- theranovis dental gel group
- Placebo group
Treatment groups
20 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov